McNaughton Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
1,082
+197
+22% +$201K 0.46% 52
2026
Q1
$814K Buy
+885
New +$897K 0.34% 53
2025
Q3
Sell
-860
Closed -$670K 76
2025
Q2
$670K Sell
860
-12
-1% -$9.32K 0.3% 54
2025
Q1
$720K Buy
872
+109
+14% +$90.7K 0.35% 54
2024
Q4
$589K Buy
763
+55
+8% +$45.5K 0.28% 45
2024
Q3
$627K Buy
+708
New +$637K 0.31% 44

Other funds holding LLY

McNaughton Wealth Management's LLY Position: Q2 2026 in Review

McNaughton Wealth Management increased its Eli Lilly (LLY) stake by 22% in Q2 2026, buying an estimated $201K and bringing the position to 1,082 shares worth $1.3M. The position accounts for 0.46% of the portfolio, ranked #52.

McNaughton Wealth Management first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McNaughton Wealth Management held 1,082 shares of Eli Lilly worth $1.3M as of Q2 2026.
  • McNaughton Wealth Management bought 197 Eli Lilly shares in Q2 2026, an estimated $201K.
  • Eli Lilly made up 0.46% of McNaughton Wealth Management's portfolio in Q2 2026, its #52 holding.
  • McNaughton Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McNaughton Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.